Patient Guide: Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 10 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07089784
Status: 🟢 Enrolling Now
Condition: Diabetes Mellitus, Type 2
Phase: PHASE1

Where You Can Participate

This study is available at 10 locations across the country.

Top locations include:
  • • Chula Vista, California
  • • Hallandale, Florida
  • • Jacksonville, Florida
  • • And 7 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003) - Join Clinical Trial NCTNCT07089784

How to Join This Clinical Trial - NCTNCT07089784

Learn how to participate in this PHASE1 trial studying an investigational therapy for Diabetes Mellitus, Type 2. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Diabetes Mellitus, Type 2. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Diabetes Mellitus, Type 2
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07089784 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 10 locations. Find a study site near you:

Clinical Research Site

Chula Vista, California 91911 - United States

Status: RECRUITING

Clinical Research Site

Hallandale, Florida 33009 - United States

Status: RECRUITING

Clinical Research Site

Jacksonville, Florida 32216 - United States

Status: RECRUITING

Clinical Research Site

Miami, Florida 33147 - United States

Status: RECRUITING

Clinical Research Site

South Miami, Florida 33143 - United States

Status: RECRUITING

Clinical Research Site

Lexington, Kentucky 40509 - United States

Status: RECRUITING

Clinical Research Site

Kansas City, Missouri 64114 - United States

Status: RECRUITING

Clinical Research Site

Springfield, Missouri 65802 - United States

Status: RECRUITING

Clinical Research Site

Knoxville, Tennessee 37920 - United States

Status: RECRUITING

Clinical Research Site

San Antonio, Texas 78209 - United States

Status: RECRUITING

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Diabetes Mellitus, Type 2:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships